Stay updated with breaking news from Column Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotech investors look at hundreds of startups each year, trying to find the best new companies. Here are the privately held, venture-backed businesses they think will take off.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
San Diego-based targeted protein degradation company Plexium said today that it has named a new member to its board of directors. The company said it appointed Brian Wong, the President and CEO of RAPT The
Rhode Island State Investment Commission, Providence, approved new alternative fund commitments totaling up to $46 million for the $10.3 billion Rhode Island Employees' Retirement System. The commission at its May 25 meeting approved commitments of up to $20 million to Crow Holdings Realty…
Surrozen (NASDAQ:SRZN – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, “Surrozen Inc. is a company pioneering targeted therapeutics which selectively activates the Wnt pathway for tissue repair and regeneration. Surrozen Inc., formerly known as […]